Landauer (NYSE: LDR) and LDR (NASDAQ:LDRH) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.
Institutional & Insider Ownership
79.6% of Landauer shares are held by institutional investors. 6.6% of Landauer shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This is a breakdown of recent ratings and target prices for Landauer and LDR, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
This table compares Landauer and LDR’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Landauer pays an annual dividend of $1.10 per share and has a dividend yield of 1.6%. LDR does not pay a dividend. Landauer pays out 57.3% of its earnings in the form of a dividend.
Valuation & Earnings
This table compares Landauer and LDR’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
LDR is trading at a lower price-to-earnings ratio than Landauer, indicating that it is currently the more affordable of the two stocks.
Landauer beats LDR on 8 of the 9 factors compared between the two stocks.
Landauer Company Profile
Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company’s Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company’s Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.
LDR Company Profile
LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company’s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company’s VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company’s Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company’s traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.
Receive News & Ratings for Landauer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer and related companies with MarketBeat.com's FREE daily email newsletter.